Clinical nonferiority evaluation on the efficacy and safety of safflower yellow pigment lyophilized power & dripping solution in the treatment of patients with angina

Chinese Journal of Evidence-Based Medicine

Volumn 5, Issue 4, 2005, Pages 276-285

  Zhang, Qiong ^a   Chen, Zhi Yang ^b,c   Wu, Lin Bin ^d   Wang, Shu Chen ^a   Zheng, Qing Shan ^c  

^a XIYUAN HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Anhui Provincial Center for Drug Clinical Evaluation   (China)

^d Certification Committee for Drugs   (China)

Author keywords

Angina; Clinical trial; Non inferiority trial; Safflower yellow pigment lyophilized dripping solution; Safflower yellow pigment lyophilized power

Indexed keywords

PLANT EXTRACT; SAFFLOWER EXTRACT; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FREEZE DRYING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; SAFFLOWER; SIDE EFFECT; STABLE ANGINA PECTORIS;

EID: 20644450335     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Zheng QS, Sun RY, Chen ZY. Sample size estimation and equivalence margin in noninferiority and equivalence trials[J]. Chinese Journal New Drugs, 2003; 12(5): 368-371.
2. Zheng QS, Sun RY, Chen ZY. Lowest sample size and its safety in clinical trials in China[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003; 8(3): 354-355.
3. Zheng XY. The guide for clinical trials of new drugs[M]. 1st Edition. Beijing; Medical Press Science of Technology of China; 2002. p. 68-73.
4. Zheng QS, Sun RY, Chen ZY. Determination of equivalence of two drugs in clinical trial[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002; 7(6): 559-561.
5. Chen ZY, Zheng QS, Sun RY, Function of the DAS software for pharmacological calculation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002; 7(6): 562-564.
6. Zheng QS, Sun RY. Common questions of rank data and the statistical treatments in pharmacodynamical statistics[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002; 7(5): 469-472.